Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Denka to Launch Rapid Antigen Test Kit for COVID-19 on August 13
August 12, 2020
- Xarelto OD Tablets Approved, Specially Developed for Japan: Bayer
August 12, 2020
- Taiho Confirms COVID-19 Cluster at Its Training Center, 8 Test Positive
August 12, 2020
- Takeda Pairs with Novavax to Roll Out Coronavirus Vaccine in Japan, Wins 30 Billion Yen in Govt Funding
August 11, 2020
- Aducanumab Accepted for FDA Review with Priority Tag; Target Date Set for March 7
August 11, 2020
- Otsuka’s 1st Half Pharma Sales Rise 7.6% as 4 Global Brands Fare Well
August 11, 2020
- Mundipharma’s Sedative Agent Anerem Now Available in Japan
August 11, 2020
- Japan Ethical Drug Sales Up 0.9% in June: Crecon
August 11, 2020
- Daiichi Sankyo, AstraZeneca to Team Up for PI of Patritumab Deruxtecan/Tagrisso Combo in EGFR-Mutated NSCLC
August 11, 2020
- Japan’s Diabetic Market to Shrink after Peaking in FY2023: Yano Research
August 11, 2020
- Telomelysin-Keytruda Combo Trial to Begin in US for Head and Neck Cancer: Oncolys
August 11, 2020
- Axcelead Chief Says Small-Molecule Drug Targets More than Doubled in Last Few Years; IPO Eyed in 4-5 Years
August 7, 2020
- Sumitomo Dainippon Eyes 100 Billion Yen Sales from Frontier Biz: President
August 7, 2020
- Some Firms Curbing Supplies of Ethical Povidone-Iodine Products after Osaka COVID-19 Data
August 7, 2020
- Opdivo Eclipses Keytruda Again in July: Encise Drug Sales Ranking
August 7, 2020
- Sales Rep Promotions in June Double against May: Intage
August 7, 2020
- GSK, KM Biologics in Adjuvant Tech Transfer Talks for COVID-19 Vaccines
August 7, 2020
- Torii Gets Japan Option Rights to Verrica’s Warts Drug
August 6, 2020
- MSD Japan Chief Wants Talks with Govt, Re-Pricing Rules Revisited to Help Innovation Thrive
August 6, 2020
- SymBio to Tap Into Global Development of Brincidofovir IV for Post-HSTC Adenovirus Infection
August 6, 2020
ページ
More than a year after Dupixent (dupilumab) became the first antibody therapy approved for COPD in Japan, drug makers are…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…